Benjamin Kim, PhD

Ben Kim is a Venture Principal at Playground Global where he helps identify the founders and companies that are revolutionizing engineered biology. At Playground, he has sourced and led investments into companies including Outpace Bio, Manifold Bio and Lassogen, where he also sits as a Board Observer. In 2022, Ben led investments into two breakthrough biotech companies, currently operating in stealth.

Prior to Playground, Ben was a PhD graduate student and an NSF Fellow at Stanford University, where he studied Bioengineering and Biomedical Engineering.
Speaking In
3:00 PM - 4:00 PM
Wednesday, June 7
This panel will discuss the evolving landscape of immunotherapy in solid tumors, with a focus on…